Publications by authors named "Kenneth A Miles"

Claim this Profile
T
Texture analysis of [F]FDG PET/CT may stratify risk in stage II colorectal cancer - discovery findings.
Louise Rice, Balaji Ganeshan, Simon Wan, Shih-Hsin Chen, David M L Lilburn, Kenneth A Miles

Eur J Nucl Med Mol Imaging· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.
Vijay Mistry, Justin R Scott, Tzu-Yang Wang, Peter Mollee, Kenneth A Miles

Cancer Imaging· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules.
Fiona J Gilbert, Scott Harris, Kenneth A Miles, Jonathan R Weir-McCall, Nagmi R Qureshi

Thorax· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling.
Fiona J Gilbert, Scott Harris, Kenneth A Miles, Jonathan R Weir-McCall, Nagmi R Qureshi

Health Technol Assess· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepancies between positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography in a cohort of oncological patients.
Geon Oh, Eoin O'Mahoney, Susanne Jeavons, Phillip Law, Stanley Ngai, Kenneth A Miles

J Med Imaging Radiat Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination bone marrow imaging using positron emission tomography (PET)-MRI in plasma cell dyscrasias: correlation with prognostic laboratory values and clinicopathological diagnosis.
Courtney J Tate, Peter N Mollee, Kenneth A Miles

BJR Open· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiologist Engagement as a Potential Barrier to the Clinical Translation of Quantitative Imaging for the Assessment of Tumor Heterogeneity.
Kenneth Alan Miles, Julia Squires, Michelle Murphy

Acad Radiol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional Clinical Value for PET/MRI in Oncology: Moving Beyond Simple Diagnosis.
Kenneth A Miles, Stefan A Voo, Ashley M Groves

J Nucl Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging biomarker roadmap for cancer studies.
James P B O'Connor, Eric O Aboagye, Judith E Adams, Hugo J W L Aerts, Sally F Barrington, Kenneth A Miles

Nat Rev Clin Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance of 18F-FDG PET Uptake in Tumor and Normal Tissues on PET/MRI and PET/CT.
W Phillip Law, Nicole Maggacis, Susanne J Jeavons, Kenneth A Miles

Clin Nucl Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gallium-68 PSMA uptake in adrenal adenoma.
W Phillip Law, Frank Fiumara, William Fong, Kenneth A Miles

J Med Imaging Radiat Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to use CT texture analysis for prognostication of non-small cell lung cancer.
Kenneth A Miles

Cancer Imaging· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal and hepatic kinetics of Tc-99m-labelled hexakis-methoxy-isobutyl Isonitrile.
Sabina Dizdarevic, Mark Aplin, Nicola Ryan, Stephen G Holt, Lawrence Goldberg, Kenneth A Miles

Drug Metab Lett· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic.
Glen J Weiss, Balaji Ganeshan, Kenneth A Miles, David H Campbell, Philip Y Cheung

PLoS One· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Old tracer for a new purpose: potential role for 99mTc-2-Methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant care.
Sabina Dizdarevic, Mark Aplin, Melanie J Newport, Nicola Ryan, Stephen Holt, Kenneth A Miles

Nucl Med Commun· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer imaging: quo vadis?
Rodney J Hicks, Kenneth A Miles

Cancer Imaging· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer.
Kenneth A Miles, Balaji Ganeshan, Manuel Rodriguez-Justo, Vicky J Goh, Zia Ziauddin

J Nucl Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.
Anita Wale, Kenneth A Miles, Barnaby Young, Charles Zammit, Anthony Williams

Eur J Nucl Med Mol Imaging· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating prognostic imaging biomarkers into clinical practice.
W Phillip Law, Kenneth A Miles

Cancer Imaging· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting tumour response.
Samuel D Kyle, W Phillip Law, Kenneth A Miles

Cancer Imaging· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT texture analysis using the filtration-histogram method: what do the measurements mean?
Kenneth A Miles, Balaji Ganeshan, Michael P Hayball

Cancer Imaging· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.
Thida Win, Kenneth A Miles, Sam M Janes, Balaji Ganeshan, Manu Shastry

Clin Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying tumour heterogeneity with CT.
Balaji Ganeshan, Kenneth A Miles

Cancer Imaging· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.
Francesca Ng, Balaji Ganeshan, Robert Kozarski, Kenneth A Miles, Vicky Goh

Radiology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-small cell lung cancer: histopathologic correlates for texture parameters at CT.
Balaji Ganeshan, Vicky Goh, Henry C Mandeville, Quan Sing Ng, Peter J Hoskin, Kenneth A Miles

Radiology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis